The role of inflammatory cytokines in diabetic nephropathy

JF Navarro-Gonzalez… - Journal of the American …, 2008 - journals.lww.com
Cytokines act as pleiotropic polypeptides regulating inflammatory and immune responses
through actions on cells. They provide important signals in the pathophysiology of a range of …

Inflammatory targets in diabetic nephropathy

J Donate-Correa, D Luis-Rodríguez… - Journal of Clinical …, 2020 - mdpi.com
One of the most frequent complications in patients with diabetes mellitus is diabetic
nephropathy (DN). At present, it constitutes the first cause of end stage renal disease, and …

Diabetic kidney disease: pathophysiology and therapeutic targets

S Toth-Manikowski, MG Atta - Journal of diabetes research, 2015 - Wiley Online Library
Diabetes is a worldwide epidemic that has led to a rise in diabetic kidney disease (DKD).
Over the past two decades, there has been significant clarification of the various pathways …

Inflammatory cytokines in diabetic kidney disease: pathophysiologic and therapeutic implications

J Donate-Correa, CM Ferri, F Sánchez-Quintana… - Frontiers in …, 2021 - frontiersin.org
Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease and a main
contributing factor for cardiovascular morbidity and mortality in patients with diabetes …

Role of inflammation in diabetic complications

JF Navarro, C Mora - Nephrology dialysis transplantation, 2005 - academic.oup.com
Diabetes mellitus, especially type 2 diabetes, is a public health problem which has reached
epidemic proportions due to the rapidly increasing rates of this disease worldwide. Target …

Pentoxifylline for renal protection in diabetic kidney disease. A model of old drugs for new horizons

J Donate-Correa, VG Tagua, C Ferri… - Journal of clinical …, 2019 - mdpi.com
Diabetic kidney disease is one of the most relevant complications in diabetes mellitus
patients, which constitutes the main cause of end-stage renal disease in the western world …

The effect of pentoxifylline on proteinuria in diabetic kidney disease: a meta-analysis

BB McCormick, A Sydor, A Akbari, D Fergusson… - American Journal of …, 2008 - Elsevier
BACKGROUND: Pentoxifylline is a potential therapeutic agent for diabetic kidney disease
because it has anti-inflammatory, antifibrotic, and hemorheological properties. STUDY …

The role of inflammation as a pathogenic factor in the development of renal disease in diabetes

C Mora, JF Navarro - Current Diabetes Reports, 2005 - Springer
Conclusions The classical pathogenic vision of diabetes mellitus as a metabolic disorder
has changed in the past years. Inflammation has been demonstrated as an important factor …

Repurposing drugs for highly prevalent diseases: pentoxifylline, an old drug and a new opportunity for diabetic kidney disease

J Donate-Correa, MD Sanchez-Niño… - Clinical Kidney …, 2022 - academic.oup.com
Diabetic kidney disease is one of the most frequent complications in patients with diabetes
and constitutes a major cause of end-stage kidney disease. The prevalence of diabetic …

Pentoxifylline for diabetic kidney disease

D Shan, HM Wu, QY Yuan, J Li… - … of systematic reviews, 2012 - cochranelibrary.com
Background Diabetic kidney disease (DKD) is associated with increased morbidity and
mortality, mostly relating to cardiovascular complications. The relevance of inflammation in …